Item(by='bsder', descendants=None, kids=None, score=None, time=1607908496, title=None, item_type='comment', url=None, parent=25405148, text='&gt; The debate seems to be pretty complex.<p>The debate is complex, but the amyloid plaque people have been steamrollering everybody else into submission--which is unfortunate as their hypothesis has failed every single time it has been put to the test.<p>However, Big Pharma is no longer backing amyloid plaque research because <i>every single drug</i> targeting them has failed for Alzheimer&#x27;s.<p>At this point, it&#x27;s very likely that amyloid <i>isn&#x27;t</i> the problem.  It&#x27;s probably a response--and likely one that occurs long after the damage is done.<p>See Derek Lowe&#x27;s blog about this stuff:\n<a href="https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;2018&#x2F;06&#x2F;12&#x2F;an-alzheimers-statement" rel="nofollow">https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;2018&#x2F;06&#x2F;12&#x2F;an...</a>\n<a href="https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;category&#x2F;alzheimers-disease" rel="nofollow">https:&#x2F;&#x2F;blogs.sciencemag.org&#x2F;pipeline&#x2F;archives&#x2F;category&#x2F;alzh...</a>')